Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas-Reference-Cited by-同舟云学术

Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas

Published:2016-06-10 Issue:9 Volume:29 Page:1050-1057
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Tian Xuejun,Pelton Ashley,Shahsafaei Ali,Dorfman David M

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2016114.pdf

Reference43 articles.

1. Simon JA, Kingston RE . Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 2009;10:697–708.

2. Fujii S, Ito K, Ito Y et al. Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation. J Biol Chem 2008;283:17324–17332.

3. Fujii S, Tokita K, Wada N et al. MEK–ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes. Oncogene 2011;30:4118–4128.

4. Geng J, Li X, Zhou Z et al. EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer. Cancer Lett 2015;359:275–287.

5. Gonzalez M, DuPrie M, Krueger H et al. Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer. Cancer Res 2001;71:2360–2370.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting MYC at the intersection between cancer metabolism and oncoimmunology;Frontiers in Immunology;2024-02-08

2. Upregulation of Enhancer of Zeste Homolog 2 (EZH2) with Associated pERK Co-Expression and PRC2 Complex Protein SUZ12 Correlation in Adult T-Cell Leukemia/Lymphoma;Cancers;2024-02-02

3. Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomas;Blood Reviews;2022-11

4. The Status and Prospects of Epigenetics in the Treatment of Lymphoma;Frontiers in Oncology;2022-04-08

5. Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics;Cancers;2022-03-13